Solvay reports preliminary Q3 2026 results and updates full-year 2026 guidance
Solvay revised its 2026 guidance after Q3 losses of €25 million due to Middle East conflict and a Saudi peroxide plant shutdown, reporting €1.03 billion in net sales and €173 million EBITDA.
Solvay’s Q3 2026 financial results were impacted by the Middle East conflict and the shutdown of the peroxide plant at the Sadara complex in Jubail, Saudi Arabia. The Group recorded a negative underlying EBITDA impact of approximately €25 million in Q3, following a €20 million impact in Q2. The shutdown alone accounted for nearly €15 million of the Q3 loss, as operations at the joint venture with Sadara (majority-owned by Saudi Aramco) remained halted.
Preliminary figures for Q3 2026 showed underlying net sales of €1.03 billion, underlying EBITDA of €173 million, and free cash flow to shareholders of €54 million from continuing operations. Solvay is exploring recovery mechanisms under the joint venture’s contractual framework to mitigate financial losses from the shutdown.
The company updated its full-year 2026 guidance, excluding potential revenue or recovery measures from Sadara for the remainder of the year. Solvay emphasized its commitment to transformation, cash generation, and cost-saving targets despite ongoing challenges. Further details will be provided with the Q3 2026 results publication on November 4, as the company remains in a quiet period.
Solvay, a global chemical company founded in 1863, operates with around 8,400 employees and reported €4.3 billion in underlying net sales in 2025. Listed on Euronext Brussels and Paris, the company focuses on sustainability and aims for carbon neutrality by 2050, addressing essential needs such as clean air, water, and sustainable materials.